Second line of Avastin and Docetaxel beyond PD by CDDP/PEM/Ava+Ava/PEM for wild and unknown of EGFR/ ALK Non-SQ NSCLC
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Bevacizumab (Primary) ; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms SEADOG
- 04 Feb 2017 Status changed from recruiting to discontinued.
- 01 Feb 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Feb 2013 New trial record